BREAKING: Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill. The move could help make the treatment available to more than half of the world’s population.
In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population.
Still, health officials said the fact that the deal was struck even before Pfizer’s pill has been authorized anywhere, could help to end the pandemic quicker.“It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
“We try to strike a very delicate balance between the interests of the , the sustainability required by generic producers and most importantly, the public health needs in lower and middle-income countries,” Burrone said.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Covid-19: Booster jabs for over-40s and Northern Ireland considers Covid passportsFive things you need to know about the coronavirus pandemic this Monday evening.
Les mer »
Austria brings back COVID-19 lockdown, this time for the unvaccinatedAustria is placing millions of people not fully vaccinated against the coronavirus in lockdown as of Monday to deal with a surge in infections to record levels and the growing strain on intensive-care units, the government said on Sunday.
Les mer »
COVID-19 surge fueled by unvaccinated children in U.K., a warning for CaliforniaThe U.K.'s challenges demonstrate how its overall vaccination efforts — while better than California's — are still not high enough for herd immunity.
Les mer »
Covid-19 Cases Rise in Pockets of North and West, Halting Delta Variant’s Decline in U.S.Covid-19 cases are climbing in the upper Midwest, Southwest and parts of the Northeast, stalling progress in ending the spread of the Delta variant just before Thanksgiving holiday travel.
Les mer »
Los Angeles Moves To Ease Covid-19 Vaccination Proof RequirementChildren between the ages of 5 and 11 will no longer need to show proof of vaccination to enter indoor spaces.
Les mer »